Kaname Ohara

607 total citations
25 papers, 505 citations indexed

About

Kaname Ohara is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Kaname Ohara has authored 25 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pharmacology. Recurrent topics in Kaname Ohara's work include Signaling Pathways in Disease (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Genetically Modified Organisms Research (3 papers). Kaname Ohara is often cited by papers focused on Signaling Pathways in Disease (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Genetically Modified Organisms Research (3 papers). Kaname Ohara collaborates with scholars based in Japan, United States and Canada. Kaname Ohara's co-authors include YASUHIRO MINE, Youichi Miyamae, Hideyo Noguchi, Yū F. Sasaki, S Katsuki, Takashi MITAMURA, H. Noguchi, Mariko Nishiyama, Richard Billington and M. R. Sahasrabudhe and has published in prestigious journals such as Brain Research, Pharmaceutical Research and Transplantation.

In The Last Decade

Kaname Ohara

24 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaname Ohara Japan 12 135 118 97 87 71 25 505
Qiang Xia China 13 210 1.6× 94 0.8× 31 0.3× 77 0.9× 27 0.4× 36 663
Kentaro Sugiyama Japan 15 273 2.0× 43 0.4× 83 0.9× 45 0.5× 9 0.1× 70 715
Lan Gao Germany 14 424 3.1× 95 0.8× 30 0.3× 13 0.1× 8 0.1× 25 647
Yasuhiko Iiboshi Japan 11 54 0.4× 88 0.7× 7 0.1× 10 0.1× 31 0.4× 20 431
Alba Galán Spain 11 150 1.1× 104 0.9× 10 0.1× 23 0.3× 157 2.2× 39 578
A Tate United States 10 141 1.0× 54 0.5× 5 0.1× 21 0.2× 44 0.6× 12 416
Stephen O. Evans United Kingdom 12 109 0.8× 13 0.1× 24 0.2× 12 0.1× 29 0.4× 16 361
Tadeusz Kroczak Canada 9 250 1.9× 35 0.3× 5 0.1× 33 0.4× 19 0.3× 20 516
Paolo Lisi Italy 16 75 0.6× 26 0.2× 5 0.1× 14 0.2× 33 0.5× 77 894
T Matsushima Japan 8 151 1.1× 36 0.3× 2 0.0× 113 1.3× 56 0.8× 16 562

Countries citing papers authored by Kaname Ohara

Since Specialization
Citations

This map shows the geographic impact of Kaname Ohara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaname Ohara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaname Ohara more than expected).

Fields of papers citing papers by Kaname Ohara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaname Ohara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaname Ohara. The network helps show where Kaname Ohara may publish in the future.

Co-authorship network of co-authors of Kaname Ohara

This figure shows the co-authorship network connecting the top 25 collaborators of Kaname Ohara. A scholar is included among the top collaborators of Kaname Ohara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaname Ohara. Kaname Ohara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stamenković, Aleksandra, Kaname Ohara, D. Michael Nelson, et al.. (2017). OXIDIZED PHOSPHATIDYLCHOLINES (OXPC) INDUCE CELL DEATH IN CARDIOMYOCYTES THROUGH FERROPTOSIS. Canadian Journal of Cardiology. 33(10). S145–S146. 1 indexed citations
2.
Moriguchi, Akira, Isamu Yamaguchi, Masaharu Hashimoto, et al.. (2002). FK960, a potential anti-dementia drug, increases synaptic density in the hippocampal CA3 region of aged rats. Brain Research. 958(2). 381–389. 4 indexed citations
3.
Miyamae, Youichi, et al.. (1998). Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (Comet) assay. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 415(3). 229–235. 66 indexed citations
4.
Bekersky, Ihor, et al.. (1998). An Evaluation of the Phototoxicity of Tacrolimus (FK506) Ointment in Hairless Mice. International Journal of Toxicology. 17(5). 541–550. 6 indexed citations
5.
Miyamae, Youichi, et al.. (1997). Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (Comet) assay.. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 393(1-2). 99–106. 59 indexed citations
6.
Ishida, Hisao, et al.. (1997). Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats. Toxicology. 123(3). 167–175. 16 indexed citations
7.
Mitamura, Takashi, et al.. (1997). Comparison of FK506 (Tacrolimus) and Glucocorticoid Ointment on Dermal Atrophogenicity in Rats.. Journal of Toxicologic Pathology. 10(2). 97–102. 17 indexed citations
8.
Fujii, Toshiyuki, et al.. (1996). Effect of Prograf (FK506) on spermatogenesis in rats. Toxicology. 109(2-3). 75–83. 27 indexed citations
9.
Ohara, Kaname, et al.. (1996). [Multicystic encephalopathy with frontal lobe-originated gelastic seizure, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus: an autopsy case].. PubMed. 36(8). 962–7. 5 indexed citations
10.
Tsutsumi, Takeshi, Keiko Nakamura, T Ogawa, et al.. (1995). TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN-12 IN PANCREATIC β-CELL. Transplantation. 59(11). 1606–1612. 2 indexed citations
11.
Hirai, Osamu, Youichi Miyamae, Miyuki Takashima, et al.. (1994). Mutagenicity tests of polyoxyethylene hydrogenated castor oil 60 (HCO-60).. The Journal of Toxicological Sciences. 19(2). 89–96. 9 indexed citations
12.
MITAMURA, Takashi, et al.. (1994). Mechanism of FK506-induced glucose intolerance in rats.. The Journal of Toxicological Sciences. 19(2). 61–65. 22 indexed citations
13.
MITAMURA, Takashi, Atsushi Yamada, Hisao Ishida, et al.. (1994). Tacrolimus (Fk506)-induced nephrotoxicity in spontaneous hypertensive rats.. The Journal of Toxicological Sciences. 19(4). 219–226. 26 indexed citations
14.
Kagayama, Akira, et al.. (1993). Oral Absorption of FK506 in Rats. Pharmaceutical Research. 10(10). 1446–1450. 35 indexed citations
15.
Ohara, Kaname, et al.. (1992). MORPHOLOGICAL AND FUNCTIONAL CHANGES OF ISLETS OF LANGERHANS IN FK506-TREATED RATS. Transplantation. 53(4). 889–893. 84 indexed citations
16.
Miyamae, Youichi, et al.. (1992). The micronucleus test of methyl methanesulfonate with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutation Research/Genetic Toxicology. 278(2-3). 117–120. 7 indexed citations
17.
Ohara, Kaname, et al.. (1990). Toxicologic evaluation of FK 506.. PubMed. 22(1). 83–6. 51 indexed citations
18.
Ohara, Kaname, et al.. (1989). Possible involvement of a tumor necrosis factor (TNF)-like mediator as an endogenous pyrogen in fever induction by Nocardia rubra cell wall skeleton (N-CWS).. Chemical and Pharmaceutical Bulletin. 37(10). 2795–2798. 1 indexed citations
19.
Hiroi, Jun, Kaname Ohara, Katsumasa Kobayashi, et al.. (1988). Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.. The Japanese Journal of Pharmacology. 46(4). 337–348. 2 indexed citations
20.
Hiroi, Jun, Kaname Ohara, T Fujitsu, et al.. (1985). The anti-inflammatory effect of auranofin.. Folia Pharmacologica Japonica. 86(6). 441–455. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026